EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting the BRAF pathway in haematological diseases

Matthew J Rees iD, Michael Dickinson iD, James Paterson, Teng F Ng, Andrew Grigg, John Moore, Piers Blombery, John F Seymour

Internal Medicine Journal · 2023

DOI: 10.1111/imj.16091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Matthew J Rees und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Hematologic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the recognition of BRAF V600E mutations in the majority of cases of hairy cell leukaemia, Erdheim–Chester disease and Langerhans cell histiocytosis, the targeted oral kinase inhibitors dabrafenib and vemurafenib have been adapted for their treatment. Like other targeted agents, these drugs produce high response rates and predictable but unique side effects. Physician familiarity is essential for the effective use of these agents. We review the Australian experience of BRAF/MEK inhibitor therapy in these rare haematological cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafHematologic NeoplasmsHumansAustraliaMaleFemaleAdultMiddle AgedAgedVemurafenibHistiocytosis, Langerhans-CellErdheim-Chester DiseaseLeukemia, Hairy CellImidazolesOximes

Substanzen

Proto-Oncogene Proteins B-rafVemurafenibBRAF protein, humandabrafenibImidazolesOximes

Autor:innen und Institutionen

  • Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Clinical Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Department of Clinical Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
  • Department of Clinical Haematology, Austin Health, Melbourne, Victoria, Australia.

ORCID-Profile: Matthew J Rees, Michael Dickinson

Zitieren

APA

Rees, M. J., Dickinson, M., Paterson, J., Ng, T. F., Grigg, A., Moore, J., Blombery, P., & Seymour, J. F. (2023). Targeting the BRAF pathway in haematological diseases. Internal Medicine Journal. https://doi.org/10.1111/imj.16091

Vancouver

Rees MJ, Dickinson M, Paterson J, Ng TF, Grigg A, Moore J, et al. Targeting the BRAF pathway in haematological diseases. Internal Medicine Journal. 2023. doi:10.1111/imj.16091

BibTeX
@article{Rees2023,
  author = {Rees, Matthew J and Dickinson, Michael and Paterson, James and Ng, Teng F and Grigg, Andrew and Moore, John and Blombery, Piers and Seymour, John F},
  title = {Targeting the BRAF pathway in haematological diseases},
  journal = {Internal Medicine Journal},
  year = {2023},
  doi = {10.1111/imj.16091}
}
Kostenlos starten →